Back
Novo Nordisk AS Stock Price Chart

Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
3
NVO
Novo Nordisk AS
Last Price:
$61.58
Seasonality Move:
5.85%
7 Day Trial
ALL ACCESS PASS
$
7

Crowdfunding to IPO: Nasdaq's Next Breakout?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.
Novo Nordisk AS Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 67.31 | Sell |
20-day SMA: | 73.04 | Sell |
50-day SMA: | 80.57 | Sell |
200-day SMA: | 108.72 | Sell |
8-day EMA: | 67.3 | Sell |
20-day EMA: | 72.45 | Sell |
50-day EMA: | 79.52 | Sell |
200-day EMA: | 99.15 | Sell |
Novo Nordisk AS Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.94 | Sell |
Relative Strength Index (14 RSI): | 25.33 | Sell |
Chaikin Money Flow: | 4329949 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (68.3 - 83.16) | Sell |
Bollinger Bands (100): | (76.16 - 101.46) | Sell |
Novo Nordisk AS Technical Analysis
Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Novo Nordisk AS Stock
Is Novo Nordisk AS Stock a Buy?
-
Novo Nordisk AS share price is 63.64 while NVO 8-day simple moving average is 67.31, which is a Sell signal.
-
The stock price of NVO is 63.64 while Novo Nordisk AS 20-day SMA is 73.04, which makes it a Sell.
-
Novo Nordisk AS 50-day simple moving average is 80.57 while NVO share price is 63.64, making it a Sell technically.
-
NVO stock price is 63.64 and Novo Nordisk AS 200-day simple moving average is 108.72, creating a Sell signal.
NVO Technical Analysis vs Fundamental Analysis
Sell
3
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy or a Sell?
-
Novo Nordisk AS stock is rated a SellThe current Novo Nordisk AS [NVO] share price is $63.64. The Score for NVO is 3, which is 94% below its historic median score of 50, and infers higher risk than normal.
Novo Nordisk AS Stock Info
Market Cap:
283.7B
Price in USD:
63.64
Share Volume:
14.5M
Novo Nordisk AS 52-Week Range
52-Week High:
148.15
52-Week Low:
60.61
Sell
3
Novo Nordisk AS (NVO)
is a Sell
Novo Nordisk AS Share Price Forecast
-
What is the Novo Nordisk AS stock price today?The Novo Nordisk AS stock price is 63.64 USD today.
-
Will NVO stock go up or go down?Novo Nordisk AS> share price is forecast to RISE/FALL based on technical indicators
-
Is Novo Nordisk AS overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Novo Nordisk AS is overvalued.
Is Novo Nordisk AS Stock a Buy?
-
Novo Nordisk AS share price is 63.64 while NVO 8-day exponential moving average is 67.30, which is a Sell signal.
-
The stock price of NVO is 63.64 while Novo Nordisk AS 20-day EMA is 72.45, which makes it a Sell.
-
Novo Nordisk AS 50-day exponential moving average is 79.52 while NVO share price is 63.64, making it a Sell technically.
-
NVO stock price is 63.64 and Novo Nordisk AS 200-day simple moving average is 99.15, creating a Sell signal.
Fundamental Analysis of Novo Nordisk AS
Is Novo Nordisk AS a good investment?
-
Analysts estimate an earnings increase this quarter of $0.27 per share, an increase next quarter of $0.13 per share, an increase this year of $0.89 per share, and an increase next year of $0.75 per share.
Technical Analysis of Novo Nordisk AS
Should I short Novo Nordisk AS stock?
-
NVO Moving Average Covergence Divergence (MACD) indicator is -4.94, suggesting Novo Nordisk AS is a Sell
-
Novo Nordisk AS Relative Strength Index (RSI) is 25.33, which suggest Novo Nordisk AS is oversold
-
The Bollinger Bands (25) for Novo Nordisk AS is (68.3 - 83.16), which suggest Novo Nordisk AS is a Sell
-
The Bollinger Bands (100) for Novo Nordisk AS is (76.16 - 101.46), which suggest Novo Nordisk AS is a Sell
* Novo Nordisk AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.